Pancreatic Cancer Research

ResearcherIowa State UniversityActive in the last 2 years

Luman Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2415-8518; OpenAlex author ID A5001238560. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. A nanovaccine induces durable and functional MUC4-targeted T cell responses against pancreatic cancer. Co-author DOI 10.1016/j.actbio.2026.04.026↗
  2. Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies. Co-author DOI 10.7150/thno.64805↗
  3. Polyanhydride nanoparticles stabilize pancreatic cancer antigen MUC4β. Co-author DOI 10.1002/jbm.a.37080↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Balaji Narasimhan · 3 shared papers, 2021–2026 · strength 0.49
  2. Shailendra Kumar Gautam · 3 shared papers, 2021–2026 · strength 0.49
  3. Surinder K. Batra · 3 shared papers, 2021–2026 · strength 0.49
  4. Maneesh Jain · 3 shared papers, 2021–2026 · strength 0.49
  5. Joyce C. Solheim · 3 shared papers, 2021–2026 · strength 0.49
  6. Aliasger K Salem · 2 shared papers, 2022–2026 · strength 0.37
  7. Sushil Kumar K · 2 shared papers, 2021–2022 · strength 0.25
  8. Kasturi Banerjee · 1 shared paper, 2026 · strength 0.24
  9. Brianna M. White · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.